ESC 365 - Late Breaking Trials II: Focus on chronic heart failure

HFA Premium Access

Late Breaking Trials II: Focus on chronic heart failure

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Miscellaneous

Session type: Special Session

Date: 30 April 2017

Time: 08:30 - 10:00

Session

12 presentations in this session

The which heart failure intervention is most cost-effective in reducing hospital stay trial.

Speaker: Professor S. Stewart (Adelaide, AU)

Discussion: The which heart failure intervention is most cost-effective in reducing hospital stay trial.

Global variations in mortality among patients with heart failure.

Speaker: Doctor H. Dokainish (Hamilton, CA)

Discussion: Global variations in mortality among patients with heart failure.

Heart failure with mid ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire EF spectrum.

Speaker: Professor L. Lund (Stockholm, SE)

Discussion: CHARM.

Empagliflozin decreases risk of kidney function decline in type 2 diabetes: slope analyses in patients with and without heart failure at baseline from the EMPA-REG OUTCOME trial.

Speaker: Professor A. Cheung (Salt Lake City, US)

Discussion: EMPA-REG OUTCOME.

Targeting heart rate to improve mortality in heart failure with reduced ejection fraction: a comparison of sinus rhythm and atrial fibrillation.

Speaker: Professor J. Cleland (Glasgow, GB)

Discussion: Targeting heart rate to improve mortality in heart failure with reduced ejection fraction: a comparison of sinus rhythm and atrial fibrillation.

6 speakers from this session

Professor Simon Stewart

University of Notre Dame Australia, Adelaide (Australia)

7 presentations

0 follower

Doctor Hisham Dokainish

McMaster University, Hamilton (Canada)

7 presentations

1 follower

Professor Lars Lund

Karolinska Institute, Stockholm (Sweden)

46 presentations

1 follower

Professor Alfred Cheung

, Salt Lake City (United States of America)

1 presentation

0 follower

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

56 presentations

2 followers

Professor Michel Komajda

Groupe Hospitalier Paris Saint-Joseph, Paris (France)

31 presentations

0 follower

This platform is supported by